The Effect of Tumor Necrosis Factor-Alpha Inhibitors on Uveitis in Patients with Ankylosing Spondylitis
Open Access
- 1 January 2019
- journal article
- research article
- Published by XMLink in Journal of Korean Medical Science
- Vol. 34 (42) , e278
Abstract
Lee S, et al. J Korean Med Sci. 2019 Oct;34(42):e278. https://doi.org/10.3346/jkms.2019.34.e278Keywords
Funding Information
- National Research Foundation of Korea (NRF2018R1D1A1A02045583)
- Asan Institute for Life Sciences, Asan Medical Center (16-484)
This publication has 27 references indexed in Scilit:
- Immunogenicity, adalimumab levels and clinical response in ankylosing spondylitis patients during 24 weeks of follow-upAnnals of the Rheumatic Diseases, 2015
- Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysisAnnals of the Rheumatic Diseases, 2015
- Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-upJAMA, 2011
- Switching biologic agents for uveitisEye, 2009
- Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label studyAnnals of the Rheumatic Diseases, 2009
- Dose escalation of the anti-TNF- agents in patients with rheumatoid arthritis. A systematic reviewRheumatology, 2007
- Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective studyAnnals of the Rheumatic Diseases, 2006
- Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti–tumor necrosis factor agents infliximab and etanerceptArthritis & Rheumatism, 2005
- Does etanercept induce uveitis?British Journal of Ophthalmology, 2003
- Systemic anti-tumor necrosis factor antibody treatment exacerbates endotoxin-induced uveitis in the ratExperimental Eye Research, 1995